%0
Generic
%T
Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non–Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial
%A Herbst, Roy S.
%A Wu, Yi-Long
%A John, Thomas
%A Grohe, Christian
%A Majem, Margarita
%A Wang, Jie
%A Kato, Terufumi
%A Goldman, Jonathan W.
%A Laktionov, Konstantin
%A Kim, Sang-We
%A Yu, Chong-Jen
%A Vu, Huu Vinh
%A Lu, Shun
%A Lee, Kye Young
%A Mukhametshina, Guzel
%A Akewanlop, Charuwan
%A de Marinis, Filippo
%A Bonanno, Laura
%A Domine, Manuel
%A Shepherd, Frances A.
%A Urban, Damien
%A Huang, Xiangning
%A Bolanos, Ana
%A Stachowiak, Marta
%A Tsuboi, Masahiro
%I American Society of Clinical Oncology (ASCO)
%@ 1527-7755
%@ 0732-183X
%D 2023
%C American Society of Clinical Oncology (ASCO)
%U http://slubdd.de/katalog?TN_libero_mab2